31/03/2026
Advances in ablative technology continue to inform minimally invasive approaches in prostate cancer care, supporting personalised treatment planning with a focus on precision and tissue preservation.
At Getz Healthcare, we support clinicians across Australia and New Zealand with access to advanced ablative solutions used in current urology practice.
Our portfolio includes the NanoKnife System from AngioDynamics, enabling focal therapy using non-thermal irreversible electroporation, and TULSA-PRO from Profound Medical Inc., an MRI-guided transurethral ultrasound ablation system designed for subtotal to whole-gland treatment.
Together, these innovations reflect evolving prostate cancer treatment pathways and support clinician choice within multidisciplinary care.
For more information, visit: https://au.getzhealthcare.com/products/urology/ablation
*Products are not available for purchase by the general public.
This link will take you to a page that’s not on LinkedIn